Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association of anticardiolipin antibodies with vascular injury: possible mechanisms.

× No keyword cloud information.

54 in total

1. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?

Authors: J Vermylen; J Arnout
Journal: J Lab Clin Med Date: 1992-07

2. Anticardiolipin antibodies in patients on regular hemodialysis: an epiphenomenon?

Authors: T Sitter; H Schiffl
Journal: Nephron Date: 1993 Impact factor: 2.847

3. The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.

Authors: A E Kabakov; V V Tertov; V A Saenko; A M Poverenny; A N Orekhov
Journal: Clin Immunol Immunopathol Date: 1992-06

4. The prevalence of vascular occlusive disease associated with antiphospholipid syndromes.

Authors: J M Bacharach; J T Lie; H A Homburger
Journal: Int Angiol Date: 1992 Jan-Mar Impact factor: 2.789

Review 5. Lipoprotein glycation and its metabolic consequences.

Authors: T J Lyons
Journal: Diabetes Date: 1992-10 Impact factor: 9.461

6. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

Authors: J D Oosting; R H Derksen; I W Bobbink; T M Hackeng; B N Bouma; P G de Groot
Journal: Blood Date: 1993-05-15 Impact factor: 22.113

7. Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity.

Authors: J E Hunt; R J Simpson; S A Krilis
Journal: Proc Natl Acad Sci U S A Date: 1993-03-15 Impact factor: 11.205

8. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus.

Authors: O Vaarala; G Alfthan; M Jauhiainen; M Leirisalo-Repo; K Aho; T Palosuo
Journal: Lancet Date: 1993-04-10 Impact factor: 79.321

9. Antiphospholipid antibodies differ in aPL cofactor requirement.

Authors: L R Sammaritano; M D Lockshin; A E Gharavi
Journal: Lupus Date: 1992-02 Impact factor: 2.911

10. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event.

Authors: E M Westerman; J M Miles; M Backonja; W R Sundstrom
Journal: Arthritis Rheum Date: 1992-09

4 in total

1. Comparison of patients with transient and sustained increments of antiphospholipid antibodies after acute ischemic stroke.

Authors: Jun Sang Yoo; Young Seo Kim; Hyun Young Kim; Hyuk Sung Kwon; Seong-Ho Koh; Sung Hyuk Heo; Bum Joon Kim; Cheryl D Bushnell; Dae-Il Chang
Journal: J Neurol Date: 2021-02-06 Impact factor: 4.849

2. Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity.

Authors: N K Tripathy; N Sinha; S Nityanand
Journal: Clin Exp Immunol Date: 2003-11 Impact factor: 4.330

Review 3. Coronavirus Disease 2019-Associated Coagulopathy.

Authors: Giuseppe Lippi; Fabian Sanchis-Gomar; Emmanuel J Favaloro; Carl J Lavie; Brandon M Henry
Journal: Mayo Clin Proc Date: 2020-10-31 Impact factor: 7.616

4. Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein I antibodies in patients with endstage renal disease.

Authors: Manuel Serrano; Jose Angel Martínez-Flores; Maria José Castro; Florencio García; David Lora; Dolores Pérez; Esther Gonzalez; Estela Paz-Artal; Jose M Morales; Antonio Serrano
Journal: J Immunol Res Date: 2014-04-10 Impact factor: 4.818

4 in total